ARCA biopharma (ABIO) Surges Higher
ARCA biopharma, Inc. (Nasdaq: ABIO) is surging higher today on heavy volume. Shares are up 41% on heavy volume. We have not seen an news to explain the spike.
ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States.
ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States.
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Rossetta Genomics (ROSG) Sells 570K Shares at $11.50/Sh
- VeriFone (PAY) Shares Slammed on Q2 Results, Guidance, Now Down ~9%
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
